GCAC Introduces Cannabis 3.0

Closing the Medical Cannabis Value Chain Loop by Michael Kryton, EQUITY IR contributing writer GCAC (CSE: APP, FSE: 2FA), the winner of the 2019 A.I of the Year Award at the prestigious 2019 Malta Medical Cannabiz Awards in early November, continues to push innovation in the medical cannabis sectors to new levels. They refer to their new vision as Cannabis…

Read More

Evolution of Blockchain

Ever since Bitcoin burst onto the scene a few years ago, cryptocurrencies and blockchain have become far better known and that has led to the development of some of today’s leading softwares. HTMLCoin is one of the software companies developing projects using their own blockchain. It is important to note that the people behind the cryptocurrency are working on myriads…

Read More

Medical Cannabis, Blockchain and AI

How Global Cannabis Application Corp is innovating the Internet of Cannabis by Michael Kryton, EQUITY IR contributing writer According to Brad Moore, CEO of Global Cannabis Application Corp (GCAC), the world view of cannabis is evolving beyond the perception of marijuana as it has been perceived (a recreational solution delivered via a joint, reefer, fatty, pot, ) to what it…

Read More

Over 2,000 Atlantans flock to Central Park for second annual Sharecare Heartbeat Festival


Fulton County Board of Commissioners declares “Sharecare Day” at family-friendly festival aimed at helping people live happier, healthier lives ATLANTA, April 17, 2019 (GLOBE NEWSWIRE) — On Saturday, April 13, 2019, more than 2,000 people gathered in Central Park in Atlanta’s Old Fourth Ward neighborhood for the second annual Sharecare Heartbeat Festival, a free, family-friendly event that provides a range…

Read More

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) Surges 45% After Signing LOI with Pharmascience, Inc.

Pivot Pharmaceuticals, Inc.

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) is a biopharmaceutical company focused on the development and commercialization of cannabis-based therapeutic pharmaceuticals, nutraceuticals, and drug delivery platform technologies. The company’s U.S.-listed shares surged 44.79% on Wednesday, April 3, 2019. Over the past month, Pivot has seen an average daily volume of 24,550 shares. However, on Wednesday, 239,787 shares traded hands, equating…

Read More

Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy

Scholar Rock Holding Corporation

Preclinical data presented at the American Association for Cancer Research annual meeting provide further support for the potential of SRK-181 to overcome primary resistance to checkpoint blockade therapy (CBT) TGFβ1-specific inhibition by SRK-181-mIgG1 was sufficient to render both TGFβ1-expressing and TGFβ1/TGFβ3 co-expressing mouse tumor models sensitive to anti-PD1 immunotherapy, suggesting TGFβ1 is the key isoform contributing to CBT resistance Combination…

Read More



The New SunTrac™ A19 Seamlessly Transitions Between GoodDay® and GoodNight® Spectrums Cocoa Beach, FL, March 29, 2019 (GLOBE NEWSWIRE) — Healthe® is excited to announce the launch of SunTrac™ A19, a product that combines engineered spectrums that have been optimized for both daytime and nighttime use into a single, dynamic, circadian lamp. Based on market demand, Healthe combined its proprietary…

Read More

Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone

Resverlogix Corp.

BETonMACE trial to continue as planned without modification CALGARY, Alberta, March 27, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announces the independent Data and Safety Monitoring Board (DSMB) has completed a ninth planned safety review for the Company’s Phase 3, BETonMACE trial for high-risk cardiovascular disease patients and recommended the study continue without modification. The…

Read More

CurvaFix Receives FDA 510(k) Clearance for CurvaFix Rodscrew Company’s Innovative Curved Device to aid Orthopedic Trauma Surgery


BELLEVUE, Wash., March 05, 2019 (GLOBE NEWSWIRE) — CurvaFix, Inc., a developer of medical devices to repair bone fractures in orthopedic trauma patients, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CurvaFix® Intramedullary Rodscrew. CurvaFix’s patented solution has the potential to improve outcomes and enable a less invasive approach in…

Read More

Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs

Vystar Corp.

WORCESTER, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) — Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter.  Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and…

Read More